Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/05/2010US7807421 Process for production of biopterin compound
10/05/2010US7807415 Methods of producing stable B-lymphocytes
10/05/2010US7807414 Anti-IL-23 antibodies, compositions, methods and uses
10/05/2010US7807413 making modified human Interleukin-8 (IL-8) protein; inhibition of the interaction of chemokines and their high-affinity receptors on leukocytes and methods for the therapeutic treatment of inflammatory diseases; glycosaminoglycan-binding proteins (GAG)
10/05/2010US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders
10/05/2010US7807396 Drug screening; Preventing amyloid plaque formation and/or growth by reacting amyloid peptides with peptidase via direction injection to the brain; gene expression; genetic engineering
10/05/2010US7807390 G-protein coupled receptor ligands and methods
10/05/2010US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule
10/05/2010US7807383 determining whether a cancer cell is sensitive to endocrine therapy by detecting the presence of binding of Deleted in Breast Cancer-1 (DBC-1) and Estrogen Receptor alpha (ER alpha )
10/05/2010US7807380 antibodies that specifically bind to native proBNP; method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP; biomarkers
10/05/2010US7807377 Method of isolating antigen-specific T cells employing artificial antigen presenting cells
10/05/2010US7807371 Methods of selecting dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers
10/05/2010US7807345 Kit which utilizes 5' untranslated region of viral sequences as probe in detection of viral infection
10/05/2010US7807186 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
10/05/2010US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
10/05/2010US7807176 Polypeptide promoting vascular endothelial cell growth
10/05/2010US7807150 Injectable composition containing crosslinkable material and cells for forming animal tissue
10/05/2010US7807148 Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a
10/05/2010US7806937 Tissue engineered female reproductive organs
10/05/2010CA2400049C Rna polymerase mutants with increased thermostability
10/05/2010CA2381438C Commercial production of chymosin in plants
10/05/2010CA2259368C Efficient nucleus transfer with foetal fibroblasts
10/05/2010CA2214721C Improved oilseed brassica bearing an endogenous oil with desirable levels of unsaturated and saturated fatty acids
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
09/2010
09/30/2010WO2010111711A2 Ganglioside biosynthesis modulators
09/30/2010WO2010111663A1 Human umbilical cord tissue cells as therapy for alzheimer' s disease
09/30/2010WO2010111659A1 Tumor-initiating cells and methods for using same
09/30/2010WO2010111631A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
09/30/2010WO2010111522A2 Mesenchymal stem cells producing inhibitory rna for disease modification
09/30/2010WO2010111422A2 Induced pluripotent stem cell generation using two factors and p53 inactivation
09/30/2010WO2010111421A2 Isoform nell-1 peptide
09/30/2010WO2010111409A2 Pluripotent stem cells
09/30/2010WO2010111278A1 Compositions of mesenchymal stem cells to regenerate bone
09/30/2010WO2010111255A1 Desiccated biologics and methods of preparing the same
09/30/2010WO2010111198A1 Compounds compositions and methods of treating cancer and fibrotic diseases
09/30/2010WO2010110974A1 Methods and compositions for tissue engineering
09/30/2010WO2010110768A1 Composition and method for producing composition for constructing tissue, and tissue construct
09/30/2010WO2010110734A1 Expansion of nk cells
09/30/2010WO2010110602A2 Method for regenerating dopaminergic neurons in the substantia nigra pars compacta using human adult stem cells or precursor cells
09/30/2010WO2010110596A2 Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same
09/30/2010WO2010110375A1 Novel lysophospholipid acyltransferase
09/30/2010WO2010110340A1 Method for amplification and high-level expression of target gene in mammalian cell, and kit for achieving the method
09/30/2010WO2010110288A1 Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
09/30/2010WO2010109916A1 Novel 2-deoxy-scyllo-inosose synthase
09/30/2010WO2010109042A1 Composition for the prevention or treatment of diabetes mellitus
09/30/2010WO2010108400A1 Method for reconstructing tissue engineered human corneal endothelium
09/30/2010WO2010108232A1 Novel receptor hetero-dimers/-oligomers
09/30/2010WO2010108215A1 Compounds and methods for modulating an immune response
09/30/2010WO2010062911A3 Compositions and methods of functionally enhanced in vitro cell culture system
09/30/2010WO2010037826A3 Method of enriching stem cells in culture
09/30/2010WO2010017216A8 Mesenchymal stromal cell populations and methods of isolating and using same
09/30/2010US20100251433 Arcelin-5 promoter and uses thereof
09/30/2010US20100251432 Novel Herbicide Resistance Genes
09/30/2010US20100251430 Highly Infectious Nucleic Acid Molecules from Pepper Mottle Virus and Plant Viral Vector Derived from the Same
09/30/2010US20100251428 Compositions And Methods For Conversion Of Aldehydes To Alkanes
09/30/2010US20100251427 Compositions and methods for producing plants with improved stress tolerance
09/30/2010US20100251426 Extra-Cellular Matrix Localized Ferritin for Iron Uptake, Storage, and Stress Tolerance
09/30/2010US20100251425 Expression of human interferon in transgenic chloroplasts
09/30/2010US20100251424 Plant regulatory sequences for selective control of gene expression
09/30/2010US20100251419 Novel nucleic acids from sesame plants
09/30/2010US20100251416 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
09/30/2010US20100251413 Cucumber hybrid px04914104
09/30/2010US20100251397 Polyploid castor plants, compositions derived therefrom and uses of same
09/30/2010US20100251396 Transgenic mice expressing human formyl peptide receptor
09/30/2010US20100251395 Using cytosine deaminases to diminish retroelement transfer from pigs to humans
09/30/2010US20100249389 Plants and seeds of corn variety cv433540
09/30/2010US20100249388 Plants and seeds of corn variety cv251054
09/30/2010US20100249383 Novel Ligand Involved In The Transmigration Of Leukocytes Across the Endothelium and Uses Therefor
09/30/2010US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide
09/30/2010US20100249372 Botulinum neurotoxin a receptor and the use thereof
09/30/2010US20100249231 HSP90 Inhibitors of Protein-Protein Interaction HSP90 Chaperone Complexes and Therapeutic Uses Thereof
09/30/2010US20100249220 Coumermycin/novobicin-regulated gene expression system
09/30/2010US20100249219 Short rna antagonist compounds for the modulation of hif-1alpha
09/30/2010US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs
09/30/2010US20100249214 Multiplex dicer substrate rna interference molecules having joining sequences
09/30/2010US20100249213 MicroRNA Signatures in Human Ovarian Cancer
09/30/2010US20100249210 Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
09/30/2010US20100249208 Novel Methods and Models for Rapid, Widespread Delivery of Genetic Material to the CNS Using Non-Viral, Cationic Lipid-Mediated Vectors
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249195 Pyridylphenyl compounds for inflammation and immune-related uses
09/30/2010US20100249184 Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction
09/30/2010US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249053 Method for inducing hepatocyte proliferation and uses thereof
09/30/2010US20100249048 Beta glycolipids for the treatment of calcification related degenerative disorders
09/30/2010US20100249044 Biogel
09/30/2010US20100249041 Compositions comprising ornithine ketoglutarate (okg)
09/30/2010US20100249034 Gfralpha3 and its uses
09/30/2010US20100249026 Albumin fusion proteins
09/30/2010US20100249022 Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins
09/30/2010US20100248989 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
09/30/2010US20100248373 Method for introducing foreign substance into cell having cell wall
09/30/2010US20100248372 Composition and Method for Modulating Plant Transformation
09/30/2010US20100248371 Methods and compositions for modulating rad51 and homologous recombination
09/30/2010US20100248370 Method and apparatus for tissue transfer
09/30/2010US20100248369 Renal-function-ameliorating agent
09/30/2010US20100248368 Biomaterial
09/30/2010US20100248367 Method for isolation of inner cell mass and method of preparation of embryonic stem cell lines using inner cell mass isolated by the same
09/30/2010US20100248366 Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes
09/30/2010US20100248365 Ganglioside biosynthesis modulators
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 1827